|1.||Tsai, Sheng-Chueh: 2 articles (10/2015 - 07/2014)|
|2.||Chang, Po-Chun: 2 articles (10/2015 - 07/2014)|
|3.||Jheng, Yi-Han: 1 article (10/2015)|
|4.||Chen, Yi-Wen: 1 article (10/2015)|
|5.||Wang, Chen-Ying: 1 article (10/2015)|
|6.||Chen, Chih-Cheng: 1 article (10/2015)|
|7.||Lin, Yu-Fang: 1 article (10/2015)|
|8.||Chong, Li Yen: 1 article (07/2014)|
|9.||Kao, Man-Jung: 1 article (07/2014)|
|10.||Weiss, M F: 1 article (08/2001)|
|1.||Wounds and Injuries (Trauma)
07/01/2014 - "The purpose of this study is to investigate the capability of N-phenacylthiazolium bromide (PTB), a glycated cross-link breaker, in the modulation of periodontitis in various disease phases. "
07/01/2014 - "N-Phenacylthiazolium bromide inhibits the advanced glycation end product (AGE)-AGE receptor axis to modulate experimental periodontitis in rats."
05/01/2000 - "Diabetes-associated mesenteric vascular hypertrophy was attenuated by treatment with N-phenacylthiazolium bromide only if given from the time of induction of diabetes. "
05/01/2000 - "The emergence of thiazolium compounds such as N-phenacylthiazolium bromide which cleave preformed advanced glycation end products (AGEs) has allowed us to explore the effects of these agents on the vascular AGE accumulation and hypertrophy associated with diabetes. "
|4.||Diabetic Nephropathies (Diabetic Nephropathy)
|2.||Advanced Glycosylation End Products
|3.||advanced glycosylation end-product receptor